Epidemiology of non-Hodgkin lymphomas;Epidemiologia nieziarniczych chłoniaków złoś liwych

Acta Haematologica Polonica

Volumn 35, Issue 2, 2004, Pages 131-144

  Sawczuk Chabin, Joanna ^a   Centkowski, Piotr ^a   Biliński, Przemysław ^b   Warzocha, Krzysztof ^a  

^a INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^b NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Epidemiology; Etiology; Lymphomas

Indexed keywords

ADOLESCENT; ADULT; AGED; AUTOIMMUNITY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CHILD; ELECTROMAGNETIC FIELD; HUMAN; INFANT; INFECTION; LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; RADIATION EXPOSURE; REVIEW; ULTRAVIOLET RADIATION;

EID: 4644316784     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Newt R, Ferlay J, Beral V, Devesa SS. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extranodal sites. Int J Cancer 1997; 72: 923-930.
2. Gurnej KA, Cartwight RA. Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 2002; 3: 95-104
3. Waterhouse J, Muir C, Correa P, Powell J. Cancer Incidence in Five Continents, Vol III, World Health Organization, International Agency for Reaserch on Cancer (IARC) Scientific Publications No. 15, Lyon, 1976.
4. Waterhouse j, Muir C, Shanmugaratman K, Powell J. Cancer Incidence in Five Continents, Vol IV, World Health Organization, IARC Sci Publ No. 42, Lyon 1982.
5. Muir C, Waterhouse J, Mack T, Powell J. Cancer Incidence in Five Continents, Vol. V, World Health Organization, IARC Sci Publ No. 88, Lyon 1987.
6. Parkin D, Muir C, Whelan S, Gao Y, Ferlay J, Powell J, Cancer Incidence in Five Continents, Vol VI, World Health Organization, IARC Sci Publ No. 120. Lyon, 1992.
7. Parkin D, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents. Vol. VII, World Health Organization, IARC Sci Publ No. 143. Lyon, 1997.
8. th ed: McGraw-Hill Companies, Inc 2001: 1237-1262.
9. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer Statistic. CA-A Cancer Journal for Clinicians 2003; 53: 5-26.
10. Walewski J. Chłoniaki złośliwe. Onkologia Kliniczna ed by Krzakowski M. 2001: 469-502.
11. Didkowska J, Wojciechowska U, Tarkowski W, Zatoński W. Nowotwory Złośliwe w Polsce w 1999 roku, Krajowy Rejestr Nowotworów, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie Zakład Epidemiologii i Prewencji Nowotworów, Warszawa 2001
12. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from non-Hodgkin's lymphomas. Leuk Res 2002; 26: 903-908.
13. Sant M, Capocaccia R, Coleman MP, Berrino F, Gatta G, Micheli A, Verdecchia A, Faivre J, Hakulinen T, Coebergh JWW, Martinez-Garcia C, Forman D, Zappone A, and the EUROCARE Working Group. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 2001; 37: 1659-1667.
14. Swerdlow A, dos Santos Silva I, Doll R. Cancer incidence and mortality in England and Wales: trends and risk factors. Oxford University Press: Oxford, 2001.
15. Pastore G, Magnani C, Verdecchia A, Pession A, Viscomi S, Coebergh JWW, and the EUROCARE Working Group. Survival of childhood lymphomas in Europe, 1978-1992: a report from the EUROCARE study. Eur J Cancer 2001; 37: 703-710.
16. Coleman MP, Esteve J, Damiȩcki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Sci Publ No 121: Lyon, 1993: 673-704.
17. Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin's lymphoma in Connecticut, 1935-1988. Cancer 1992; 70: 840-849.
18. Groves F, Linet M, Travis L, Devessa S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histological subtype in the United States from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.
19. Serraino D, Salamina G, Franceschi S. The epidemiology of AIDS-associated non-Hodgkin lymphoma in the World Health Organization European Region. Br J Cancer 1992; 66: 912-916.
20. Reynolds T. Non-Hodgkin lymphoma rate climbed rapidly. J Natl Cancer Inst 1991; 83: 232-234.
21. Cartwright R. Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain. Cancer Res 1992; 52 (Suppl.): 5441-5442.
22. Carli P, Boutron M, Maynadie M, Baily F, Caillot D, Petrella T. Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS. Br J Cancer 1994; 70: 713-715.
23. Cartwright R, McNally R. Epidemiology of non-Hodgkin's lymphoma. Cambridge Medical Reviews Hematol Oncol 1994; 3: 1-34.
24. McNally R, Alexander F, Staines A, Cartwight R. A comparsion of three methods of analysis for age-period-cohort models with application to incidence data on non-Hodgkin's lymphoma Int J Epidemiol 1997; 26: 32-46.
25. National Cancer Institute of Canada (NCIC). Canadian Cancer Statistics 2001. NCIC: Toronto, Canada 2001; 15-47.
26. Devessa S, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992; 52 (Suppl.): 5432-5440.
27. Clarke C, Glaser S. Changing in incidence of non-Hodgkin lymphomas in the United States. Cancer 2002; 94: 2015-2023.
28. Eltom M, Jemal A, Mbulaiteye S, Devessa S, Biggar RJ. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 2002; 94: 1204-1210.
29. Liu S, Semenciw R, Mao Y. Increasing incidence of non-Hodgkin's lymphoma in Canada, 1970-1996: age-period-cohort analysis. Hematol Oncol 2003; 21: 57-66
30. Cartwright R, McNally R, Weatherbee L. Epidemiology of non-Hodgkin's lymphoma. Armitage J, Burnett A, Newland A, Keating A: Hematological Oncology, Vol. 3, Cambridge, UK, Cambridge University Press, 1994: 1-34.
31. Burmeister L. Cancer mortality in Iowa farmers, 1971-78. J Natl Cancer Inst 1981; 66: 461-464.
32. Viel J, Richardson S. Lymphoma, multiple myeloma and leukemia among French farmers in relation to pesticide exposure. Soc Sci Med 1993; 27: 771-777.
33. Wigle D, Semenciw R, Wilkins K. Mortality study of Canadian male farm operators: Non-Hodgkin lymphoma mortality and agricultural practices in Saskatchewan. J Natl Cancer Int 1990; 82: 575-582.
34. Christie D, Robinson K, Gordon I, Bisby J. A prospective study in the Australian petroleum industry.II. Incidence of cancer. Br J Ind Med 1991; 48: 511-514.
35. Ott M, Teta M, Greenberg H. Lymphatic and hematopoietic tissue cancer in chemical manufacturing environmet. Am J Ind Med. 1989; 16: 631-643.
36. Rothman N, Cantor KP, Blair A, Bush D, Brock JW, et al. Anested case-control study of non-Hodgkin lymphoma and serum organochlorine residues. Lancet 1997; 350: 240-244.
37. Sama S, Martin T, Davies L, Kriebel D. Cancer incidence among Massassuchetts firefighters. Am J Ind Med. 1990; 18: 47-54.
38. Zahm S, Weisenburger D, Babbitt P, Saal R, Vaught J, Blair A. Use of hair coloring products and the risk of lymphoma, multiple myeloma and chronic lymphocytic leukemia. Am J Public Health 1992; 82: 990-997.
39. Cantor K, Blair A, Everentt G. Hair dye use and risk of leukemia and lymphoma. Am J Public Health 1988; 78: 570-571.
40. National Radiological Protection Board. ELF electromagnetic felds and the risk of cancer. Report of an Advisory Group on Non-Ionising Radiation. Documents of the NRPB, vol 12, no 1. Chilton: NRPB, 2001.
41. National Radiological Protection Board. Health effects of ultraviolet radiation. Report of Advisory Group on Non-Ionising Radiation. Documents of the NRPB, vol 13, no. 1. Chilton: NRPB, 2002.
42. Peach H, Barnett N. Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma. Hematol Oncol 2001; 19: 67-80.
43. Catassi C, Fabiani E, Corrao G, Barbato M. Risk of non-Hodgkin's lymphoma in celiac disease-effect of a gluten diet. Gut 1989; 30: 333-338.
44. Wong-Staal F, Gallo R. The familly of human T-lymphotropic leukemia viruses: HTLV-I as the cause of adult T cel leukemia and HTLV-III as the cause of aquired immunodeficiency syndrome. Blood 1985; 65: 253-263.
45. Siegel R, Gartenhaus R, Kuzel T. Human T-cell lymphotropic-I- associated leukemia/lymphoma Curr Treat Oncol 2001 Aug; 2: 291-300.
46. Lyons S, Liebovitz D. The role of human viruses in pathogenesis of lymphoma. Sem Oncol 1998; 25: 461-475.
47. Oksenhendler E, Boulanger E, Galicier L. High incidence of Kaposi sarcoma- associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castelman disease. Blood 2002; 7: 2331-2336.
48. Hegge U, Ruzicka T, Tyring S. Update on Kaposi's sarcoma and other HHV8 associated disease. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002; 2: 344-352.
49. Ferri C, Caracciolo F, Zignego A. Hepatitis C virus infection in patients with non-Hodgkin lymphoma. Br J Heamatol 1994; 88: 392-394.
50. Luppi M, Grazia Ferrari M. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996; 10: 351-355.
51. Mazzaro C, Zagonel V, Monfardini S. Hepatitis C infection and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550.
52. Germanidis G, Haioun C, Pourquier J. Hepatitis C virus infections in patients with overt B-cell non-Hodgkin lymphoma in French center. Blood 1999; 93: 1778-1779.
53. Rabkin C, Tess B, Christianson R, Wright W, Waters D, Alter H, Van Den Derg B. Prospective study of hepatitis C viral infections as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-4242.
54. Herne K, Talpur R. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sezary syndrome. Blood 2003; 6: 2132-2135.
55. Wotherspoon A. Helicobacter pylori infection and gastric lymphoma. Br Med Bull 1998; 54: 79-85.
56. Parsonnet J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E, Orentreich N, Vogelman J, Friedman G. Helicobacter pylori infection and gastric lymphoma. N Eng J Med 1994; 330: 1267-2771.
57. Sutcliffe N, Smith C, Speight P, Isenberg D. Mucosa-associated lymphoid tissue lymphomas in two patients with rheumatoid arthritis on second agents and secondary Sjogren syndrome. Rheumatology 2000; 39: 185-188.
58. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients threated with methotrexate a 3-year prospective study in France. Blood 2002; 99: 3009-3015.
59. Wolfe F. Inflamatory activity, but not methotrexate or prednisone use predicts non-Hodgkin's lymphoma in rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
60. Filipovich C, Mathur A, Kamat D, Shapiro R. Primary immunodeficiencies: genetic risk factor for lymphoma. Cancer Res 1992; 52: 5465-5467.
61. Dotti G, Fiocchi R, Motta T, Mammana C, Gotti E. Lymphomas occurring late after solid-organ transplantation: influens of treatment on the clinical outcome. Transplantation 2002; 74: 1095-1102.
62. Opelz G, Henderson R. Incidence of non-Hodgkin's lymphoma in kidney and heart transplant recipient. Lancet 1993; 342: 1514-1516.
63. Curtis R, Travis L, Rowlings P. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
64. Kotlarek-Haus S, Haus O. Chłoniaki u osób zakażonych HIV. Acta Haematol Pol 2000; 3: 249-258.
65. Swedlow A, Barber J, Vaughan Hudson G. Risk of second malignancy after Hodgkin's disease in collaborative British cohort the relation to the age and treatment. J Clin Oncol 2000; 18: 498-509.
66. Swedlow A, Douglas A, Vaughan Hudson G, Vaughan Hudson B, MacLennan. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationship to host factors, histology and stage of Hodgkin's disease and splenectomy. Br J Cancer 1993; 68: 1006-1011.